Revolutionizing Workplace Wellness: How Ivím Health’s Corporate Wellness Programs Benefit Employers and Enhance Employee Well-Being
In today’s business world, healthy employees are a key driver of company success. As more employers recognize this, the demand for effective corporate wellness programs continues to rise. Ivím Health is leading the charge with its innovative … Read more
Does Insurance Cover Wegovy® (semaglutide), Ozempic®, (semaglutide) or Compounded Semaglutide? Understanding Your Options
For those considering Wegovy® (semaglutide), Ozempic® (semaglutide), or compounded semaglutide for weight loss or as a treatment option for type 2 diabetes management, gaining clarity on the financial implications is important. This overview examines costs with insurance … Read more
Semaglutide Fatigue: Understanding and Overcoming This Common Side Effect
If you’re experiencing fatigue while taking Ozempic® (semaglutide), Wegovy®(semaglutide), or compounded semaglutide, you’re not alone. Learn how to manage this common side effect and maintain your energy levels. Fortunately, this fatigue is often temporary and manageable with … Read more
What To Eat On Semaglutide: Top Food Choices for Weight Loss and Health
Understanding what to eat while taking Ozempic® (semaglutide), Wegovy® (semaglutide), or compounded semaglutide is crucial for maximizing weight loss benefits. This guide will provide a comprehensive list of foods to eat while on semaglutide and highlight the … Read more
Comprehensive Weight Loss Programs at Ivím Health: Flexible Memberships with GLP-1 Medications and Klarna Payments
FDA notice on Zepbound™/Mounjaro® shortage: On December 19th, 2024, the U.S. Food and Drug Administration determined that the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, has ended. Patients may continue receiving essential copies through … Read more
Zepbound® (tirzepatide) Dosage Charts: A Comprehensive Guide
FDA notice on Zepbound®/Mounjaro® shortage: The U.S. Food and Drug Administration has determined the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, has ended. Schedule a visit with an Ivim provider to discuss what this … Read more
What Is Ivím Health’s Online Weight Loss Program Membership?
At Ivím Health, our mission is to deliver unparalleled, personalized care that goes far beyond basic healthcare—and our membership model allows us to do just that. We’re proud to offer so much more than just weight loss … Read more
Semaglutide Weight Loss Dosage Chart: Everything You Need to Know
FDA notice on Wegovy®/Ozempic® shortage: On February 21st, 2025, the U.S. Food and Drug Administration determined that the shortage of semaglutide injection, a glucagon-like peptide 1 (GLP-1) medication, has ended. Patients may continue receiving essential copies through … Read more
